19 Juillet 2017
FDA approves Vosevi for Hepatitis C
The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis. Vosevi is a ...
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm567467.htm